Supplier profile
Merck Healthcare Germany GmbH
Every public-sector award we hold for this supplier, across Germany, from 1 Nov 2022 to 29 Dec 2025.
Awards won
14
all time
Attributed value
€3
7 shared, unvalued
Buyers
4
public bodies
Active
2022–2025
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 8 | not attributable |
| PBMG eG | 3 | €1 |
| IKK classic | 2 | €2 |
| AOK Baden-Württemberg | 1 | not attributable |
What they win
Awards
All 14 awards we hold
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 ↗PBMG eGawarded 29 Dec 2025
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 23 Jan 2025
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Merck Serono GmbH zu Mavenclad ↗IKK classic€1awarded 20 Nov 2024
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Merck Serono GmbH zu Mavenclad ↗IKK classic€1awarded 20 Nov 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 12 Jun 2024
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Januar 2024 ↗PBMG eG€1awarded 16 Feb 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026 ↗DAK-Gesundheitshared awardawarded 1 Feb 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026 ↗DAK-Gesundheitshared awardawarded 1 Feb 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Somatropin, ATC H01AC01 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 2 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Somatropin, ATC H01AC01 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 1 Jul 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cladribin, ATC L04AA40 für die Zeit 01.12.2022 - 30.11.2024 ↗DAK-Gesundheitawarded 1 Dec 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cladribin, ATC L04AA40 für die Zeit 01.12.2022 - 30.11.2024 ↗DAK-Gesundheitawarded 1 Dec 2022
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a, ausschließl. für die Zeit 01.11.2022-31.10.2023 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Nov 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a, ausschließl. für die Zeit 01.11.2022-31.10.2023 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Nov 2022
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.